Clinical Trial Of Ketamine Tablets Shows Promising Results For Treatment-Resistant Depression
A phase 2 clinical trial of 231 patients with treatment-resistant depression found that the oral use of an extended-release tablet of ketamine could help prevent another depressive episode.
A phase 2 clinical trial of 231 patients with treatment-resistant depression found that the oral use of an extended-release tablet of ketamine could help prevent another depressive episode.
What's Your Reaction?
